The cell-based therapy for cartilage or bone requires a large number of cells; serial passages of chondrocytes are, therefore, needed. However, fates of expanded chondrocytes from extra fingers remain unclarified. The chondrocytes from human epiphyses morphologically changed from small polygonal cells to bipolar elongated spindle cells and to large polygonal cells with degeneration at early passages. Gene of type II collagen was expressed in the cells only at a primary culture (Passage 0) and Passage 1 (P1) cells. The nodules by implantation of P0 to P8 cells were composed of cartilage and perichondrium. The cartilage consisted of chondrocytes with round nuclei and type II collagen-positive matrix, and the perichondrium consisted of spindle cells with type I collage-positive matrix. The cartilage and perichondrium developed to bone with marrow cavity through enchondral ossification. Chondrogenesis and osteogenesis by epiphyseal chondrocytes depended on replication number in culture. It is noteworthy to take population doubling level in correlation with pharmaceutical efficacy into consideration when we use chondrocytes for cell-based therapies.
Introduction
Epiphyseal cartilage of long bone is destined to develop to bone with marrow cavity and articular cartilage. The epiphyseal cartilage continues to proliferate and undergoes enchondral ossification until apparent growth ceases at adolescence and eventually is replaced with bone except for articular surface which remains cartilaginous throughout life [1] . Chondrocytes in culture have an ability to generate cartilage in vivo and can be a tool to simulate developmental process. Our previous study demonstrated that human infant epiphyseal chondrocytes can also simulate developmental process of epiphyseal cartilage as well as other cell types [2] . Chondrocytes in culture regenerate the cartilaginous tissue by a short-term implantation in vivo and exhibited enchondral ossification after a longer period. The cell-based therapeutic strategies in cartilage and bone require serial cell passage of expanded chondrocytes for acquisition of a large number of cells. In this study, we extensively characterized chondrocytes derived from human epiphyseal cartilage in correlation with regenerative medicine.
Materials and Methods

Human Epiphyseal Chondrocytes (HECs).
HECs were obtained from epiphyseal cartilage of the phalanx and metacarpal bones of amputated supernumerary digits with polydactyly of finger or toe of 10 patients (Table 1) . Signed informed consents were obtained from the parents of the donors. Isolation of HECs was performed as described previously [2] . Briefly, after confirmation of no development of secondary ossification center in the epiphyseal ends of bone, the epiphyseal cartilage was dissected out from bones and cut into piece of 1 mm 3 . The diced fragments were placed in 0.2% trypsin/0.02% EDTA solution (ImmunoBiological Laboratories Co, Ltd. Gunma, Japan) diluted with PBS at 37 ∘ C for 30 min and incubated in Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich Japan K.K., Tokyo) with 0.1% collagenase (Wako Pure Chemical Industries, Ltd. Osaka, Japan) at 37 ∘ C for 7 to 10 h. After centrifuge of the isolated cells, the cell-pellets were resuspended in DMEM. Isolated chondrocytes were grown in MF basal medium with 1% fetal calf serum (Toyobo Life Science, Fukui, Japan) at a #2  11  Toe  #3  12  Toe  #4  7  Toe  #5  10  Toe  #6  12  Finger  #7  9  Toe  #8  11  Finger  #9  12  Toe  #10 11 Finger density of 0.5-1 × 10 5 cells/100 mm dish and 10 mm chamber slide by a monolayer culture in 37 ∘ C and 5% CO 2 incubator.
Cytology.
Culture cells on the chamber slides were stained by Papanicolaou's method after fixation in 100% ethanol and by senescence-associated ß-galactosidase [3] .
Reverse Transcription Polymerase Chain Reaction (RT-PCR).
Total RNA was isolated from HECs, using the RNeasy kit (Qiagen, Valencia, Ca, USA). Total RNA (2 g) was reverse-transcribed to cDNA at 50 ∘ C for 50 min in a volume of 20 L containing the following reagents: 0.5 mM dNTP mix, 0.5 M oligo-dT 12-18 primer, first strand buffer, RNase inhibitor, and 200 unit Superscript III (RNase H-free reverse transcriptase). All the reagents were purchased from Invitrogen (Carlsbad, CA, USA). After terminating the reaction at 70 ∘ C for 15 min, 1 U RNase H (Invitrogen) was added to the reaction mixture, followed by incubation at 37 ∘ C for 10 min to remove RNA. PCR was performed in a total volume of 50 L, using the primers (Table 2 ) and the Ex Taq Hot Start Version (Takara Bio Inc., Shiga, Japan). The PCR products were electrophoresed and visualized on ethidium bromidestained 1.5% agarose gels.
Cell Implantation.
To determine the ability of HECs in a monolayer culture, cells of 1.5-3 × 10 7 in number were subcutaneously inoculated into the back skin of 6-to 8-weekold, NOD/Shi-scid, IL-2R null (NOG) mice (Central Institute for Experimental Animals, Kanagawa, Japan). HECs (#1, #2, #3, #4, #5, #9, and #10) were injected into 7 mice for 2-week implantation. HECs at P0 (#6, #7, #8, #9, and #10), P1 (#6, #7, #8, #9, and #10), P2 (#7, #9, and #10), and P3 (#7, #9, and #10) were injected into 5, 5, 3, and 3 mice, respectively, for longer period of implantation. The subcutaneous nodules of the mice were removed and photographed. Their weight and size were then measured.
Microscopic Analysis with
Immunohistochemistry. Subcutaneous nodules in mouse backs were fixed in 4% paraformaldehyde and embedded in paraffin, after decalcification with 5% EDTA (pH 6.8) solution if necessary. Cutting sections were deparaffinized, dehydrated, and stained with hematoxylin and eosin (HE) and with toluidine blue (pH 7.0) and alcian blue (pH 2.5) for cartilaginous matrix.
For immunohistochemical analysis, the following primary antibodies were used: mouse monoclonal anti-human collagen type II (clone: II-4c11) and type I (clone: I-8H5) antibodies (Daiichi Fine Chemical Co., Ltd., Toyama, Japan). Additionally, anti-human antibodies (Dako, Glostrup, Denmark) of vimentin (clone: V9), CD31 (clone: JC70A), and CD34 (clone: QBEnd 10) were used. These antibodies specifically react with human antigens but not with mouse antigens [2] . Cut paraffin sections were deparaffinized, dehydrated, and treated with 2% proteinase K (Dako) in Tris-HCl buffer pH 7.5 solution for 5 min at room temperature or heated in ChemMate Target Retried Solution (Dako) for 5-20 min in a high-pressure steam sterilizer for epitope unmasking. After blocking of endogenous peroxidase by 1% hydrogen peroxide/methanol for 15 min, the sections were incubated at room temperature for 60 min in primary antibodies diluted with antibody diluent (Dako). The sections were washed with As the passage number increased, the boundary of two portions became ill-defined. P4 to P8 cells exhibited spindle-shaped dedifferentiated chondrocytes, accompanied with reactions of inflammatory cells, macrophages, and foreign-body giant cells. 
Results
HEC in Culture.
HECs were fibroblast-like in morphology at a primary culture. HECs slowly proliferated until 4th day after start of the cultivation and then rapidly proliferated at 5-6th day (Figure 1(a) ). The cells reached to senescence before population doubling level (PDL) 60. PDLs of the senesced cells were 52.4 in an average at Passage 8. We then examined HECs for expression of cartilage-associated genes at each passage by RT-PCR analysis (Figure 1(b) ). The type II collagen gene was expressed at P0 and P1 but was not detected at P2 to P8. The genes for collagen types I, III, and X remained to be expressed from P0 to P8.
HECs showed extensive morphological alternations during passage expansions ( long cytoplasmic processes, indistinct nuclear chromatin structures, and occasional vacuolations. P8 cells became enlarged and deeply stained with senescence-associated ß-galactosidase.
Implantation of HECs for Two Weeks.
We subcutaneously implanted HECs at each passage to investigate ability of chondrogenesis and osteogenesis in vivo. P0 and P1 cells generated the nodules that hardly changed in size, weight, and degree of transparency with whitish color on surface ( Figure 2 ). In contrast, P2 cells formed the nodules that decreased in weight, size, and degree of transparency. The nodule by P0 cells was clearly divided into two different parts, cartilage composing of chondrocytes with lacunae and abundant extracellular matrix in the center and perichondrium with spindle cells-layers at the periphery (Figure 3 ), as demonstrated in the previous study [2] . Extracellular matrix in the cartilage generated by P0 and P1 cells demonstrated metachromasia with toluidine blue stain. Vimentin was detected in both chondrocytes and perichondrial spindle cells. Type II collagen-positive matrix was diffusely distributed in the cartilage by P0 and P1 cells, and type I collagen-positive matrix was localized in the perichondrium. Unlike P0, P1, and P2 cells, P3 to P8 cells generated small and flattened nodules without clear vascular invasion on opaque, whitish to brownish surface color, and failed to generate cartilage. Microscopically, the nodules showed fibrous tissues with lack of chondrocytes with lacunae and the increase of spindle and dedifferentiated chondrocytes. The fibrous tissue included inflammatory cells, reactions of foreign-body giant cells, and vascular invasions.
Long-Term Observation of Cartilage and
Bone by P0 to P2 HEC Implantation. We then followed up the nodule of bone and cartilage following implantation of HEC at P0 (PDL 7) until 20 and 40 weeks (Figure 4) . Macroscopically, the nodules showed smooth surface with white-yellow and reddish portion in color at 20 weeks and 40 weeks. Enchondral ossification progressed in the cartilage at 20 weeks and new bone and marrow cavity were formed (Figures 4(a)-4(g) ).
Bone marrow cavity was surrounded by osteoid and new bone with osteoblasts, osteoclasts, immature adipocytes, endothelial cells, and fibroblastoid cells. The nodules with bone and cartilage increased in size and weight and became reddish on surface and developed prominent vascular networks at 40 weeks (Figures 4(h)-4(q) ). The nodules resembling articular cartilage and cortical bone with periosteum demonstrated the thin trabecular and spicular networks of the lamellar bone with diffuse accumulation of unilocular mature adipocytes and vascular development.
At 20 weeks, type II collagen was detected in the extracellular matrix of cartilage but gradually reduced (Figure 4(e) ). In contrast, type I collagen became positive in matrix of osteoid, new bone, and periosteum (Figure 4(f) ). The CD 31-positive endothelial cells were present along with the vessels at the periphery of cartilage (Figure 4(g) ). At 40 weeks, type II collagen remained positive in peripheral cartilage and occasionally in core of enchondral ossification (Figures 4(m) and 4(n)). Type I collagen-positive matrix was clearly distributed in trabecular bone (Figures 4(o) and 4(p) ). The vasculogenesis with CD 31-positive endothelial cells became prominent (Figure 4(q) ).
We then investigated if P1 cells are able to generate cartilage and bone like P0 cells ( Figure 5 ). To this end, we performed 10 implantations of P1 cells (PLD 10). P1 cells under PDL 12 exhibited cartilage formation with enchondral ossification after implantation. The nodules at 25 weeks were composed of the perichondrium and cartilage with accumulation of extracellular matrix (Figures 5(a) and 5(b) ). The cartilage was composed of small chondrocytes with round or occasional spindle nuclei and lacunae and covered by perichondrium with thin layer of elongated fibroblastlike spindle cells ( Figure 5 
CD31 100 m (g) Figure 4 : Long-term observation at the P0 (PDL 7) cell-implanted sites. P0 (HEC #6) cell-implanted sites were analyzed at 20 weeks (a-g) and 40 weeks (h-q). Macroscopic examination of the P0 cell-nodules (606 mg in weight) at 20 weeks showed smooth and whitish surface with focal reddish portion and vascular networks (a). Microscopic examination showed progress of enchondral ossification (b) with new bone formation and poor marrow cavity (c). Marrow cavity consisted of osteoblasts, osteoclasts, undifferentiated mesenchyme cells, and a few of immature adipocytes (d). Cartilage and core of the enchondral ossification were positive for COL II (e). Perichondrium, bone, and osteoid were positive for COL I (f). Endothelium in the early marrow cavity was positive for CD31 (g). Macroscopic examination of the P0 cell-nodules (686 mg in weight) at 40 weeks showed increased reddish portion with prominent vascular networks on the surface (h). Bone marrow cavity was surrounded by the cartilage and bone (i), which morphologically resembled to articular cartilage (j) and cortical bone (k), respectively. Trabecular bone was extended with the fatty marrow (l). Peripheral cartilage (m) and core of the enchondral ossification (n) were positive for COL II. Perichondrium, periosteum (o), and trabecular bones (p) were positive for COL I. The vessels in the bone marrow cavity were positive for CD31 (q). and osteoclastogenesis were confirmed; however, bone marrow cavity with differentiation into trabecular bone or mature adipocytes was not detected. Type I collagen-positive matrix diffusely distributed at the perichondrium at 25 weeks (Figure 5(e) ) and at the osteoid and new bone in the enchondral ossification at 41 weeks ( Figure 5(k) ). Vasculogenesis with CD 34-positive endothelia ( Figure 5 (f)) started to be seen during enchondral ossification at 41 weeks ( Figure 5(l) ). P1 cells (PDL 14) generated cartilage that were macroscopically flattened or club-shaped, translucent, and whitish surface, exhibited type II collagen-positive matrix in the cartilage at 25 and 42 weeks after the implantation, but failed to develop bone marrow even after follow-up observation ( Figure 6 ). The cartilage at 25 weeks level was composed of small chondrocytes with round or spindle nuclei and lacunae and hypertrophic cells with large lacunae. The perichondrium showed the structure of thick or thin layers with elongated fibroblast-like spindle cells (Figure 6(b) ). The nodules at 42 weeks showed morphologies similar to those at 25 weeks, except for a decrease of hypertrophic cells with large lacunae and slight increase of chondrocyte with spindle nuclei and narrow lacunae in number and increase in eosinophil of the perichondrial matrix and in thickness of the perichondrium. Type II collagen-positive matrix was detected in the cartilage at 25 weeks ( Figure 6(d) ) and 42 weeks ( Figure 6(i) ). Type I collagen-positive matrix was distributed in the thick perichondrium at 25 weeks ( Figure 6 (e)) and 42 weeks ( Figure 6(j) ). In contrast, P2 cells also generated cartilage that was maintained for up to 17 weeks (Figure 7) . Macroscopically, the cartilage showed translucent and smooth surface that were white, partly light brown, or yellow in color (Figure 7(a) ). The cartilages at 9 weeks consisted of hypertrophic chondrocytes with round or spindle nuclei and large lacunae ( Figures  7(b) and 7(c) ). The cartilages at 17 weeks showed increase of small chondrocyte with spindle nuclei and eosinophilic extracellular matrix at the perichondrium (Figures 7(g) and 7(h)). Type II collagen-positive matrix remained in the cartilage at 9 weeks (Figure 7(d) ) and at 17 weeks (Figure 7(i) ). Type I collagen-positive matrix was distributed in the perichondrium at 9 weeks (Figure 7(e) ) and extended into the cartilage at 17 weeks, in addition to the perichondrium (Figure 7(j) ).
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Lack of Chondrogenic Activity in P3
Cells. P3 cells (PDL 23) generated fibrous tissue that was macroscopically translucent and flattened and tightly adhered to the subcutaneous tissue (Figure 8(a) ). The tissue was ill-defined in the boundaries between the perichondrium and cartilage (Figures 8(b) and 8(c) ). Type II collagen-positive matrix was irregularly distributed in the cartilage (Figure 8(d) ). Type I collagen-positive matrix was irregularly found in the cartilage and not overlapped with type II collagen-positive matrix (Figure 8(e) ).
Discussion
For the cell-based therapeutic strategies of cartilage and bone formation, the expansion of cultivation is required to gain sufficient number of cells and to preserve for a long period in recipient; therefore, the detailed studies are essential with regard to the characteristics of expanded and/or dedifferentiated chondrocytes in vitro and in vivo. We have previously reported that chondrocytes from epiphyseal cartilage at a primary culture have the ability to regenerate cartilage and to develop bone with marrow cavity through enchondral ossification in vivo [2] . This present study demonstrated the detailed alterations of the human infant epiphyseal chondrocytes during expansions from P0 to P8 cells in monolayer culture and the ability of in vivo chondrogenesis and osteogenesis by implantation and longterm observation after implantation. The fate of cartilage generated by chondrocytes depended on population doubling levels of chondrocytes in culture. Primarily, implanted chondrocytes need to retain the abilities to generate cartilage with production of type II collagenpositive cartilaginous matrix and to produce type I-positive perichondrium. In addition to chondrocytes, participation of undifferentiated mesenchymal cells that differentiate into osteoblasts, adipocytes, and endothelia is required for bone development through enchondral ossification [1, 4, 5] . In our previous study [2] , we showed that perichondrial spindle cells participate in bone development as undifferentiated mesenchymal cells after implantation of cultivated chondrocytes, like perichondrial cells in a cartilage anlage of human embryonic bone.
Chondrogenic ability of cultivated chondrocytes is associated with surface markers, gene expression, morphology, synthesis of the type of collagen, and capacity of redifferentiation, using human articular cartilage and other cartilages [6, 7] or animal [8] as cell sources [9] [10] [11] . Surface markers include CD26 for the chondrogenic potential of human articular chondrocytes [12] and ratio of CD54 to CD44 as an index of differentiation status [6] . Morphology of chondrocytes changes from a differentiated round to polygonal cell shape to dedifferentiated fibroblast-like phenotype [8, 13] . In gene expression, type II collagen is essential for chondrocytes capable of generating cartilage [7] and inversely correlated with increasing PDLs [14] . The ratio of type I and type II collagen, defined as an index of cell differentiation, is significantly higher at a primary culture and become lower along with expansion [12] . In vivo chondrogenesis is also associated with PDLs of cultivated chondrocytes in rabbit [ 15, 16] , bovine [17] , and human fetal and adult articular chondrocytes [18] . Chondrocytes at a primary culture from articular cartilage show mature and well-formed cartilage with extracellular matrix of type II collagen; however, those with chondrocytes with a longer cultivation do not generate cartilage with type II collagen but form fibrous tissue [15] and almost same results have been presented in chondrocytes from the costal cartilage [16] . Chondrocytes can be not only isolated from cartilage, but also differentiated from somatic stem cells including mesenchymal stem cells and marrow stromal cells [2, 19, 20] . Chondrocytes have recently been generated from pluripotent stem cells like other cell types [2, 21, 22] . To reverse dedifferentiation process during cultivation, several approaches have been developed. Dedifferentiated chondrocytes after a longer cultivated period regain chondrogenic activity by the high-density culture method [23] . To acquire sufficient cell number for cartilage engineering, the coculture system of in vitro expanded dedifferentiated chondrocytes with small numbers of primary chondrocyte is useful to redifferentiate the dedifferentiated cells and form thicker cartilage tissue with type II collagen [17] .
Wnt/beta-catenin signaling may be involved in maintenance of chondrogenic activity [24] . Cultivation medium is shown to affect cell phenotypes in vitro. In addition to the redifferentiation strategies, the selection approach was employed to isolate functionally active chondrogenic cells with high levels of type II collagen from dedifferentiated cells or hypertrophic cells with product of type X collagen for in vivo chondrogenesis [18] .
With regard to epiphyseal cartilage, however, the study in concerning cytological descriptions of the isolated culture cells have not been presented and there are a few morphological studies in vivo on the new bone formation by the implantation of chondrocytes isolated from cartilage of rat [25] and mouse [26] . In human epiphyseal chondrocytes, nodular structures resembling mature articular cartilage are formed by primary culture of human fetal epiphyseal chondrocytes for long-term of up to 180 days on hydrogel substrate [27] , although the experiment in passage-expansion of cultivated cells was not performed. Our observations in the present studies of epiphyseal chondrocytes showed the morphology in vivo on the regenerated cartilage and new bone formation with marrow cavity by the implantation of expanded cells for short to long period. Large cartilage without ossification needs to be formed by implantation of cultivated cells with higher PDLs by usage of cytokines in future.
Finally, the present studies showed the changes in cytology and gene expression of the infant epiphyseal chondrocytes in a monolayer culture by cell expansion from the P0 to P8 cells. The experiment in vivo by implantation of expanded cells for a short to long periods demonstrated the fate of the epiphyseal chondrocytes and elucidated that the proceeded passage-cells can regenerate the tissue for a short period; however these tissues cannot be preserved for a longer period and absorbed, except those of the P0 and P1 cells. The bone development through enchondral ossification occurred in cartilage by the P0 cells and by the P1 cells with only lower PDLs. The P1 cells with rather higher PDLs form the articular cartilage-like tissue without ossification. These findings would be a help of chondrocyte-based therapy.
